Global Adiponectin Testing Market Size study, By Product Type (Adiponectin ELISA Kits, Adiponectin Enzyme Immunoassay Kits, Others), By End User (Hospitals, Diagnostic Laboratories, Research Laboratories), and Regional Forecasts 2022-2028
発行: Bizwit Research & Consulting LLP
List of figures
Global Adiponectin Testing Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Adiponectin Testing is used to determine the levels of adiponectin in blood. Adiponectin is a hormone that is released from fat cells. It has application in diagnosis of metabolic disorders such as Type 2 diabetes. Also, determination of the adiponectin level in plasma can help to estimate the risk of coronary disease. Rising prevalence of metabolic disorders and increasing healthcare awareness among consumers as well as product launches from leading market players are key drivers for growth of Adiponectin Testing Market. For instance, International Diabetes Federation - Globally, around 537 million adults (20-79 years) are living with diabetes and this number is projected to grow to 643 million by 2030 and 783 million by 2045. Furthermore, according to Statista - in 2019, global health spending per person was estimated at USD 1,129, and it is estimated to grow to USD 1,515 by 2050. Moreover, in January 2020, Randox, UK, released an analyte-specific reagent for adiponectin. This new reagent is intended for use in automated clinical chemistry testing. Also, increasing number of research laboratories and diagnostic centres and rising healthcare infrastructure in emerging economies are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, high product cost associated with Adiponectin Testing kits impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Adiponectin Testing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing advancements in healthcare sector and growing prevalence of metabolic disorders. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising geriatric population and increasing penetration of leading market players, would create lucrative growth prospects for the Adiponectin Testing market across the Asia Pacific region.
Major market players included in this report are:
Stratech Scientific ltd.
Thermo fisher Scientific Inc.
Boster Biological Technology
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type
Adiponectin ELISA Kits
Adiponectin Enzyme Immunoassay Kits
By End User
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Adiponectin Testing Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers